Merck&#39;s Vioxx Should Have Been Recalled Years Ago, Lancet Says
Merck &amp; Co.&#39;s Vioxx painkiller&#39;s heart risk was evident in studies four years before the drug was recalled -- and it should have been pulled from the market then, according to a study published in the medical journal Lancet.
- Bayer HealthCare, a U.S.-based unit of Bayer AG , stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet the main goal of improved overall survival.